Commentary on: Padeliporfin Vascular-targeted Photodynamic Therapy Versus Active Surveillance in Men With Low-risk Prostate Cancer (CLIN1001 PCM301): An Open-label, Phase 3, Randomized Controlled Trial.
Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
James
J
Johnston
Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Werner J
WJ
Struss
Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
Peter C
PC
Black
D001429:Bacteriochlorophylls / Q000008:administration & dosage*; D001706:Biopsy; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage; D011467:Prostate / Q000000981:diagnostic imaging; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013997:Time Factors; D016896:Treatment Outcome
D001429:Bacteriochlorophylls; D017319:Photosensitizing Agents; C456120:palladium-bacteriopheophorbide; D017430:Prostate-Specific Antigen